Sequential Therapy With Recombinant Human IGF-1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa: A Randomized, Placebo-Controlled Trial is a research paper published in Journal of Bone and Mineral Research (2021). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1UL1TR002541‐01
National Center for Research Resources
Grant: 1 UL1 RR025758
NIH HHS
Grant: 1UL1TR001102
Ipsen Biopharmaceuticals
Grant: Drug only
National Institutes of Health
Grant: K23 DK115903
NIH HHS
Grant: K24 HL092902
NIH HHS
Grant: R01 DK052625
NIH HHS
Grant: T32 DK007028
NCRR NIH HHS
Grant: UL1 RR025758
NCATS NIH HHS
Grant: UL1 TR000170
NCATS NIH HHS
Grant: 8 UL1 TR000170
NCATS NIH HHS
Grant: UL1 TR001102
NCATS NIH HHS
Grant: UL1 TR002541
NIH HHS
Grant: 1UL1TR002541-01
The Harvard Clinical and Translational Science Center
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals